rs4646301

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003060.4(SLC22A5):​c.394-2970G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0768 in 152,270 control chromosomes in the GnomAD database, including 579 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.077 ( 579 hom., cov: 32)

Consequence

SLC22A5
NM_003060.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0410

Publications

7 publications found
Variant links:
Genes affected
SLC22A5 (HGNC:10969): (solute carrier family 22 member 5) Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
SLC22A5 Gene-Disease associations (from GenCC):
  • systemic primary carnitine deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • short QT syndrome
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.263 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003060.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC22A5
NM_003060.4
MANE Select
c.394-2970G>A
intron
N/ANP_003051.1
SLC22A5
NM_001308122.2
c.394-2756G>A
intron
N/ANP_001295051.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC22A5
ENST00000245407.8
TSL:1 MANE Select
c.394-2970G>A
intron
N/AENSP00000245407.3
SLC22A5
ENST00000435065.7
TSL:1
c.394-2756G>A
intron
N/AENSP00000402760.2
SLC22A5
ENST00000448810.6
TSL:1
n.394-2970G>A
intron
N/AENSP00000401860.2

Frequencies

GnomAD3 genomes
AF:
0.0768
AC:
11688
AN:
152152
Hom.:
582
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0610
Gnomad AMI
AF:
0.109
Gnomad AMR
AF:
0.0497
Gnomad ASJ
AF:
0.112
Gnomad EAS
AF:
0.276
Gnomad SAS
AF:
0.0731
Gnomad FIN
AF:
0.0769
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0754
Gnomad OTH
AF:
0.0770
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0768
AC:
11691
AN:
152270
Hom.:
579
Cov.:
32
AF XY:
0.0763
AC XY:
5684
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0611
AC:
2538
AN:
41550
American (AMR)
AF:
0.0497
AC:
760
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.112
AC:
390
AN:
3468
East Asian (EAS)
AF:
0.275
AC:
1423
AN:
5170
South Asian (SAS)
AF:
0.0729
AC:
352
AN:
4828
European-Finnish (FIN)
AF:
0.0769
AC:
816
AN:
10612
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0754
AC:
5131
AN:
68020
Other (OTH)
AF:
0.0771
AC:
163
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
530
1060
1589
2119
2649
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0744
Hom.:
721
Bravo
AF:
0.0741
Asia WGS
AF:
0.133
AC:
462
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.2
DANN
Benign
0.34
PhyloP100
-0.041
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4646301; hg19: chr5-131711100; API